Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
CBIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.00%104.101.1%$1332.57m
GILDGilead Sciences, Inc.
0.00%72.440.9%$675.30m
AMGNAmgen Inc.
0.00%170.001.1%$499.55m
BIIBBiogen Inc.
1.02%317.161.2%$472.85m
REGNRegeneron Pharmaceuticals, Inc.
0.00%391.592.7%$363.74m
ALXNAlexion Pharmaceuticals, Inc.
0.00%110.871.9%$288.55m
VRTXVertex Pharmaceuticals Incorporated
0.00%147.411.9%$237.28m
INCYIncyte Corporation
0.00%105.472.5%$187.59m
ALNYAlnylam Pharmaceuticals, Inc
0.00%127.5110.6%$184.43m
ILMNIllumina, Inc.
0.00%209.023.5%$165.18m
NKTRNektar Therapeutics
0.00%44.996.1%$146.11m
JUNOJuno Therapeutics, Inc.
0.00%58.6413.5%$138.44m
BMRNBioMarin Pharmaceutical Inc.
0.00%82.884.4%$117.68m
SRPTSarepta Therapeutics, Inc.
0.00%56.1116.8%$117.17m
BLUEBluebird Bio, Inc.
0.00%163.2017.2%$116.94m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address hemophilia condition. Its candidate product includes Factor Xa. It also offers anti-complement products. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.